Skip to main content
. 2021 Jun 15;11(6):e047007. doi: 10.1136/bmjopen-2020-047007

Table 3.

Factors associated with being ‘severe’ at the time of admission

OR 95% CI P value
Days between onset and admission 1 0.99 to 1.01 0.96
 Age 1.04 1.03 to 1.04 <0.001
 Male 2.09 1.76 to 2.48 <0.001
Comorbidities
 Cardiovascular disease 1.48 1.04 to 2.10 0.028
 Cerebrovascular disease 1.33 0.95 to 1.85 0.097
 Chronic respiratory disease 2.51 1.67 to 3.78 <0.001
 Asthma 1.24 0.87 to 1.77 0.24
 Liver disease 0.97 0.61 to 1.54 0.892
 Diabetes 1.34 1.09 to 1.64 0.006
 Obesity diagnosed by physicians 1.75 1.26 to 2.45 0.001
 Severe renal disease or dialysis 1 0.54 to 1.88 0.991
 Solid tumour 1.2 0.82 to 1.77 0.351
 Leukaemia 0.34 0.08 to 1.39 0.132
 Lymphoma 0.42 0.16 to 1.11 0.081
 Hypertension 1.33 1.08 to 1.64 0.008
 Hyperlipidaemia 0.91 0.70 to 1.19 0.49
Treatments prior to COVID-19
 Use of steroid in 1 month 1.65 0.52 to 5.22 0.394
 Chemotherapy in 3 months 1.47 0.72 to 3.0 0.286
 Immunosuppressants* use in 3 months 1.35 0.69 to 2.64 0.384

*Immunosupprenssants other than steroids.